Aegon’s US pivot crossed a decisive threshold this week: the long-established Dutch group confirmed New York City as its future corporate headquarters and appointed a new President and COO — accelerating a transformation that will legally erase the Aegon name from holding-company letterheads by 2028. For European insurance executives tracking transatlantic capital flows, the announcement is a structural signal, not a rebranding exercise.
New York by Mid-2027, Delaware by January 2028
New York City has been selected as the location for Aegon’s future corporate headquarters, with the office expected to open in mid-2027 and to house selected corporate functions alongside leadership team members. The choice of Manhattan — rather than Aegon’s existing Iowa base at Transamerica — signals an explicit bid for proximity to US capital markets, asset management counterparties, and global institutional investors.
The HQ move is the visible layer of a deeper legal restructuring. The group will redomicile via a continuation of Aegon Ltd. into Transamerica Inc., a Delaware corporation, subject to shareholder approval. Completion is targeted for January 1, 2028, with the holding company renamed Transamerica Inc. and group financial reporting transitioning from IFRS to US GAAP for full-year 2027. The accounting switch alone carries material consequences for analysts and investors who track the group under European standards — comparable metrics with peers such as Generali’s strong recent operating result underpinned by European diversification, will require restating.
An Extraordinary General Meeting of shareholders is anticipated in Q4 2026 to approve the redomiciliation and related governance changes. That EGM vote is the gating catalyst: without it, none of the subsequent legal, supervisory or accounting changes proceed on schedule. The one-time implementation cost of the redomiciliation is estimated at approximately EUR 350 million, to be incurred between H2 2025 and H1 2028.
Will Fuller Steps Up: COO Role Recognises Transamerica’s Weight
Will Fuller has been named President and Chief Operating Officer of Aegon, effective January 1, 2027. In his expanded role, Fuller will oversee Transamerica, International businesses, and Aegon Asset Management, reporting directly to CEO Lard Friese. The scope of the mandate is striking: it consolidates under a single executive the revenue engine and the investment management arm that together define Aegon’s earnings profile.
Fuller joined Aegon in March 2021 as Transamerica’s President and CEO, bringing senior experience from Lincoln Financial Group and Merrill Lynch. His elevation reflects a board conviction that operational integration — not just legal restructuring — is the harder half of the pivot. This pattern of accelerated insider promotion echoes the leadership reconfiguration seen elsewhere in the sector: when Swiss Re named Dean Galligan to lead L&H Transactions as the longevity pipeline builds, it similarly signalled that the next strategic phase would be executed by operators close to the business rather than by imported turnaround profiles.
CEO Lard Friese will himself relocate to the United States in early 2027, retaining responsibility for group strategy and performance. The physical relocation of group CEO and COO to the US makes the governance shift unambiguous: Amsterdam retains no operational primacy. Primary financial supervision will transfer from the Dutch central bank (DNB) and EIOPA to US state regulators — a switch with long-term implications for how Aegon-as-Transamerica is stress-tested and capital-managed relative to European counterparts.
Transamerica at the Core: Why the US Pivot Is Structural
The strategic arithmetic is straightforward once the numbers are exposed. Transamerica represents approximately 70% of Aegon’s group operations and is the largest single contributor to the group’s profit and cash flow. Domiciling the holding company in a jurisdiction outside its primary profit centre was, in this framing, the anomaly — the redomiciliation merely corrects the structural misalignment.
The 2025 results validate the operational rationale. Aegon’s full-year 2025 operating result rose 15% to EUR 1.7 billion. The full-year net result climbed 45% to EUR 980 million. Operating capital generation of EUR 1.3 billion exceeded the EUR 1.2 billion target. Within that picture, the US engine is the dominant driver: Transamerica’s 2025 operating result run-rate stood at USD 1.4 to 1.6 billion, with a target to grow that figure by approximately 5% per annum over the following two years.
Aegon’s World Financial Group expanded to over 95,000 licensed agents in 2025, with individual new life sales rising 30%. The distribution scale underscores what Transamerica is: a mass-market US life and retirement platform with a reach that most European peers cannot replicate through organic growth. For context on how cross-border footprint building is unfolding across the sector, the DB Insurance–Fortegra acquisition demonstrated how Asian carriers are paying premium multiples to enter the US specialty market — the direction of capital is converging on America from multiple origins simultaneously.
Capital Position and the Dutch Legacy: A Managed Transition
The transition’s financial scaffolding is robust enough to absorb the restructuring cost. Aegon’s group Solvency II ratio stood at 183% at June 30, 2025, and 184% at year-end 2025, within the group’s target range. The group returned EUR 1.1 billion to shareholders in 2025 through dividends and share buybacks, including a full-year dividend of EUR 0.40 per share — an 11% increase. Strong capital return while absorbing EUR 350 million in restructuring costs signals that the balance sheet has headroom.
The Dutch legacy is being managed, not abandoned. Vereniging Aegon will contribute EUR 500 million to a new Dutch charitable entity, Stichting Aegon Fonds Nederland, to support social initiatives in the Netherlands. The foundation endowment serves a dual purpose: it provides a tangible acknowledgement of the group’s deep Dutch roots, and it addresses the political optics of a national institution shifting its legal center of gravity across the Atlantic. The move also joins a broader pattern of European insurance leadership reshaping: AXA’s Thomas Buberl secured a renewed mandate to pursue an AI and P&C growth strategy — the contrast with Aegon’s approach illustrates that large European groups are diverging sharply on where they see the next decade’s value creation.
For reinsurers and treaty counterparties, the supervisory transition from DNB/EIOPA to US state regulators deserves close monitoring. Solvency II capital requirements and US risk-based capital (RBC) frameworks differ materially in their treatment of long-duration liabilities, real estate assets, and off-balance-sheet structures. Once Transamerica Inc. is the group holding company, Solvency II ratios will no longer be the primary lens for group-level solvency assessment — and analysts will need to rebuild their valuation frameworks accordingly.
Mini-FAQ
When will Aegon formally become Transamerica Inc. and what triggers the change?
What happens to Aegon’s Dutch roots and Netherlands stakeholders?
How material is the one-time cost of the redomiciliation and can the group absorb it?
Sources
- Aegon — New York headquarters selection and Will Fuller appointment as President and COO
- Aegon — second-half and full-year results including operating result, net result and World Financial Group metrics
- Aegon — full-year results press release covering capital generation target and dividend per share
